Screening druggable targets and predicting therapeutic drugs for COVID-19 via integrated bioinformatics analysis
Since the outbreak of coronavirus disease 2019 in China, numerous research institutions have invested in the development of anti-COVID-19 vaccines and screening for efficacious drugs to manage the virus.
